S&P 500   5,253.21 (+0.09%)
DOW   39,764.17 (+0.01%)
QQQ   444.19 (-0.14%)
AAPL   171.13 (-1.26%)
MSFT   420.21 (-0.29%)
META   488.37 (-1.11%)
GOOGL   151.27 (+0.27%)
AMZN   180.06 (+0.13%)
TSLA   177.03 (-1.56%)
NVDA   904.68 (+0.24%)
NIO   4.66 (-0.21%)
AMD   180.99 (+0.78%)
BABA   72.19 (+0.84%)
T   17.69 (+0.80%)
F   13.23 (+1.30%)
MU   119.23 (+0.08%)
CGC   9.03 (-5.45%)
GE   176.13 (-2.22%)
DIS   122.15 (+0.97%)
AMC   3.84 (-11.52%)
PFE   27.86 (+0.29%)
PYPL   66.83 (+0.39%)
XOM   115.59 (+0.54%)
S&P 500   5,253.21 (+0.09%)
DOW   39,764.17 (+0.01%)
QQQ   444.19 (-0.14%)
AAPL   171.13 (-1.26%)
MSFT   420.21 (-0.29%)
META   488.37 (-1.11%)
GOOGL   151.27 (+0.27%)
AMZN   180.06 (+0.13%)
TSLA   177.03 (-1.56%)
NVDA   904.68 (+0.24%)
NIO   4.66 (-0.21%)
AMD   180.99 (+0.78%)
BABA   72.19 (+0.84%)
T   17.69 (+0.80%)
F   13.23 (+1.30%)
MU   119.23 (+0.08%)
CGC   9.03 (-5.45%)
GE   176.13 (-2.22%)
DIS   122.15 (+0.97%)
AMC   3.84 (-11.52%)
PFE   27.86 (+0.29%)
PYPL   66.83 (+0.39%)
XOM   115.59 (+0.54%)
S&P 500   5,253.21 (+0.09%)
DOW   39,764.17 (+0.01%)
QQQ   444.19 (-0.14%)
AAPL   171.13 (-1.26%)
MSFT   420.21 (-0.29%)
META   488.37 (-1.11%)
GOOGL   151.27 (+0.27%)
AMZN   180.06 (+0.13%)
TSLA   177.03 (-1.56%)
NVDA   904.68 (+0.24%)
NIO   4.66 (-0.21%)
AMD   180.99 (+0.78%)
BABA   72.19 (+0.84%)
T   17.69 (+0.80%)
F   13.23 (+1.30%)
MU   119.23 (+0.08%)
CGC   9.03 (-5.45%)
GE   176.13 (-2.22%)
DIS   122.15 (+0.97%)
AMC   3.84 (-11.52%)
PFE   27.86 (+0.29%)
PYPL   66.83 (+0.39%)
XOM   115.59 (+0.54%)
S&P 500   5,253.21 (+0.09%)
DOW   39,764.17 (+0.01%)
QQQ   444.19 (-0.14%)
AAPL   171.13 (-1.26%)
MSFT   420.21 (-0.29%)
META   488.37 (-1.11%)
GOOGL   151.27 (+0.27%)
AMZN   180.06 (+0.13%)
TSLA   177.03 (-1.56%)
NVDA   904.68 (+0.24%)
NIO   4.66 (-0.21%)
AMD   180.99 (+0.78%)
BABA   72.19 (+0.84%)
T   17.69 (+0.80%)
F   13.23 (+1.30%)
MU   119.23 (+0.08%)
CGC   9.03 (-5.45%)
GE   176.13 (-2.22%)
DIS   122.15 (+0.97%)
AMC   3.84 (-11.52%)
PFE   27.86 (+0.29%)
PYPL   66.83 (+0.39%)
XOM   115.59 (+0.54%)
NYSE:A

Agilent Technologies (A) Stock Price, News & Analysis

$146.83
-0.54 (-0.37%)
(As of 09:39 AM ET)
Today's Range
$146.65
$147.68
50-Day Range
$128.10
$149.36
52-Week Range
$96.80
$151.58
Volume
37,743 shs
Average Volume
1.62 million shs
Market Capitalization
$43.03 billion
P/E Ratio
34.96
Dividend Yield
0.64%
Price Target
$138.29

Agilent Technologies MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.53 Rating Score
Upside/​Downside
5.9% Downside
$138.29 Price Target
Short Interest
Healthy
1.23% of Float Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-1.78
Upright™ Environmental Score
News Sentiment
0.14mentions of Agilent Technologies in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$9.22 M Sold Last Quarter
Proj. Earnings Growth
10.16%
From $5.51 to $6.07 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.18 out of 5 stars

Computer And Technology Sector

129th out of 588 stocks

Analytical Instruments Industry

8th out of 28 stocks

A stock logo

About Agilent Technologies Stock (NYSE:A)

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment focuses on genomics, nucleic acid contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, and biomolecular analysis businesses. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and offers services portfolio, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, and consulting services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

A Stock Price History

A Stock News Headlines

Your $200 account credit is about to expire
Update to MarketBeat All Access and Save $300 on Your Annual Subscription
Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
Assessing Agilent Technologies: Insights From 6 Financial Analysts
See More Headlines
Receive A Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Agilent Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 1/24 Dividend
12/29/2023
Dividend Payable
1/24/2024
Last Earnings
2/27/2024
Today
3/27/2024
Ex-Dividend for 4/24 Dividend
4/01/2024
Dividend Payable
4/24/2024
Next Earnings (Estimated)
5/28/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Industry
Analytical instruments
Sub-Industry
Life Sciences Tools & Services
CUSIP
00846U10
Employees
18,100
Year Founded
1999

Price Target and Rating

Average Stock Price Target
$138.29
High Stock Price Target
$165.00
Low Stock Price Target
$90.00
Potential Upside/Downside
-6.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.53
Research Coverage
17 Analysts

Profitability

Net Income
$1.24 billion
Pretax Margin
19.78%

Debt

Sales & Book Value

Annual Sales
$6.83 billion
Cash Flow
$6.51 per share
Book Value
$21.11 per share

Miscellaneous

Free Float
N/A
Market Cap
$43.20 billion
Optionable
Optionable
Beta
1.11

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Should I Buy Agilent Technologies Stock? A Pros and Cons Explained

These insights were generated using artificial intelligence. They are based on proprietary MarketBeat data, news articles, and custom LLM A.I. algorithms. This analysis of Agilent Technologies was last updated on Tuesday, March 26, 2024 at 10:44 PM.

Pros

Here are some ways that investors could benefit from investing in Agilent Technologies, Inc.:

  • Agilent Technologies, Inc. operates in the analytical instruments industry, which is known for steady demand due to the essential nature of its products in various scientific fields.
  • The company offers a wide range of cutting-edge products in segments like Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab, catering to diverse market needs.
  • Agilent Technologies, Inc. has a strong focus on innovation and research, consistently introducing new technologies and solutions to stay competitive in the market.
  • Recent financial reports indicate a positive revenue growth trend for Agilent Technologies, Inc., reflecting the company's ability to generate income and potentially increase shareholder value.
  • Investors may find Agilent Technologies, Inc. stock price attractive, considering its performance relative to industry peers and market trends.

Cons

Investors should be bearish about investing in Agilent Technologies, Inc. for these reasons:

  • Market competition in the analytical instruments industry is intense, leading to potential pricing pressures and challenges in maintaining market share.
  • Economic downturns or fluctuations in research and healthcare funding could impact the demand for Agilent Technologies, Inc.'s products and services.
  • Changes in regulatory environments, especially in the life sciences and diagnostics sectors, may pose compliance risks and affect the company's operations.
  • Investing in technology companies like Agilent Technologies, Inc. carries inherent risks related to rapid technological advancements and potential obsolescence of current products.
  • Global economic uncertainties or geopolitical events could influence Agilent Technologies, Inc.'s international operations and revenue streams.

A Stock Analysis - Frequently Asked Questions

Should I buy or sell Agilent Technologies stock right now?

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Agilent Technologies in the last year. There are currently 1 sell rating, 6 hold ratings and 10 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" A shares.
View A analyst ratings
or view top-rated stocks.

What is Agilent Technologies' stock price target for 2024?

17 brokerages have issued 1-year price targets for Agilent Technologies' stock. Their A share price targets range from $90.00 to $165.00. On average, they anticipate the company's share price to reach $138.29 in the next twelve months. This suggests that the stock has a possible downside of 5.9%.
View analysts price targets for A
or view top-rated stocks among Wall Street analysts.

How have A shares performed in 2024?

Agilent Technologies' stock was trading at $139.03 at the beginning of the year. Since then, A stock has increased by 5.7% and is now trading at $146.91.
View the best growth stocks for 2024 here
.

Are investors shorting Agilent Technologies?

Agilent Technologies saw a increase in short interest in March. As of March 15th, there was short interest totaling 3,580,000 shares, an increase of 30.7% from the February 29th total of 2,740,000 shares. Based on an average daily trading volume, of 1,610,000 shares, the short-interest ratio is presently 2.2 days. Approximately 1.2% of the shares of the stock are short sold.
View Agilent Technologies' Short Interest
.

When is Agilent Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 28th 2024.
View our A earnings forecast
.

How were Agilent Technologies' earnings last quarter?

Agilent Technologies, Inc. (NYSE:A) issued its earnings results on Tuesday, February, 27th. The medical research company reported $1.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.07. The medical research company earned $1.66 billion during the quarter, compared to analysts' expectations of $1.59 billion. Agilent Technologies had a net margin of 18.35% and a trailing twelve-month return on equity of 27.09%. The business's revenue for the quarter was down 5.5% compared to the same quarter last year. During the same quarter last year, the company earned $1.37 EPS.
Read the conference call transcript
.

How often does Agilent Technologies pay dividends? What is the dividend yield for Agilent Technologies?

Agilent Technologies announced a quarterly dividend on Wednesday, February 21st. Investors of record on Tuesday, April 2nd will be given a dividend of $0.236 per share on Wednesday, April 24th. This represents a $0.94 annualized dividend and a yield of 0.64%. The ex-dividend date is Monday, April 1st.
Read our dividend analysis for A
.

Is Agilent Technologies a good dividend stock?

Agilent Technologies (NYSE:A) pays an annual dividend of $0.94 per share and currently has a dividend yield of 0.65%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 22.38%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, A will have a dividend payout ratio of 15.49% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for A.

How will Agilent Technologies' stock buyback program work?

Agilent Technologies announced that its board has initiated a stock buyback program on Monday, January 9th 2023, which permits the company to buyback $2,000,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to repurchase up to 4.4% of its shares through open market purchases. Shares buyback programs are typically a sign that the company's board believes its stock is undervalued.

What guidance has Agilent Technologies issued on next quarter's earnings?

Agilent Technologies updated its second quarter 2024 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of 1.170-1.200 for the period, compared to the consensus estimate of 1.270. The company issued revenue guidance of $1.6 billion-$1.6 billion, compared to the consensus revenue estimate of $1.6 billion.

What is Mike McMullen's approval rating as Agilent Technologies' CEO?

452 employees have rated Agilent Technologies Chief Executive Officer Mike McMullen on Glassdoor.com. Mike McMullen has an approval rating of 98% among the company's employees. This puts Mike McMullen in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Agilent Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Agilent Technologies investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), QUALCOMM (QCOM), PayPal (PYPL), AT&T (T), Broadcom (AVGO), Boeing (BA) and Skyworks Solutions (SWKS).

Who are Agilent Technologies' major shareholders?

Agilent Technologies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (8.63%), Vanguard Group Inc. (8.63%), Massachusetts Financial Services Co. MA (4.52%), Wellington Management Group LLP (3.37%), Price T Rowe Associates Inc. MD (2.56%) and Northern Trust Corp (1.36%). Insiders that own company stock include Boon Hwee Koh, Dominique Grau, Heidi Fields, Henrik Ancher-Jensen, Jacob Thaysen, Michael R Mcmullen, Michael Tang, Padraig Mcdonnell, Philip Binns, Rodney Gonsalves and Samraat S Raha.
View institutional ownership trends
.

How do I buy shares of Agilent Technologies?

Shares of A stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Agilent Technologies have any subsidiaries?
The following companies are subsidiares of Agilent Technologies: ACEA BIO, ATN Microwave, Accelicon Technologies, Acqiris, Advanced Analytical Technologies, Agilent Raman Spectroscopy, Agilent Technologies Luxco S.à.r.l., Agilent Technologies Luxembourg Holding S.à.r.l., Agilent Technologies Singapore (Global) Pte Ltd., Agilent Technologies Singapore (Holding) Pte. Ltd., Agilent Technologies Singapore (International) Pte. Ltd., Agilent Technologies World Trade Inc., Agilent's Interoperability Certification Labs, American Holographic, Aurora SFC Systems, BIOCIUS Life Sciences, BioTek Instruments, BioTek Instruments LLC, Biosystem Development, Cartagenia, Computational Biology, Dako Denmark, Dako Denmark ApS, Escort Instruments, Genohm, Gradient Design Automation, Halo Genomics, J&W Scientific, Lab901, LaserGen, Lionheart Technologies LLC, Luxcel Biosciensces Ltd., MTS Nano Instruments, MV Technology, Molecular Imaging Corp., Multiplicom, Novelx, Objective Systems Integrators, PXIT, ProZyme Inc, Qosnetics, RVM Scientific, RedSwitch, Resolution Bioscience, SAFCO, Seahorse Bioscience, Silicon Genetics, Stratagene, SynPro, TILL Photonics, ULTRA Scientific, Varian, Velocity11, Wavefront Research, Xpedion Design Systems, Young In Scientific Co. Ltd, Zymed, and iLab Solutions.
Read More
This page (NYSE:A) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners